These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
522 related articles for article (PubMed ID: 28601935)
1. A novel systemic immune-inflammation index predicts survival and quality of life of patients after curative resection for esophageal squamous cell carcinoma. Wang L; Wang C; Wang J; Huang X; Cheng Y J Cancer Res Clin Oncol; 2017 Oct; 143(10):2077-2086. PubMed ID: 28601935 [TBL] [Abstract][Full Text] [Related]
2. The predictive value of a preoperative systemic immune-inflammation index and prognostic nutritional index in patients with esophageal squamous cell carcinoma. Zhang H; Shang X; Ren P; Gong L; Ahmed A; Ma Z; Ma R; Wu X; Xiao X; Jiang H; Tang P; Yu Z J Cell Physiol; 2019 Feb; 234(2):1794-1802. PubMed ID: 30070689 [TBL] [Abstract][Full Text] [Related]
3. Systemic Immune-Inflammation Index Predicts Prognosis of Patients with Esophageal Squamous Cell Carcinoma: A Propensity Score-matched Analysis. Geng Y; Shao Y; Zhu D; Zheng X; Zhou Q; Zhou W; Ni X; Wu C; Jiang J Sci Rep; 2016 Dec; 6():39482. PubMed ID: 28000729 [TBL] [Abstract][Full Text] [Related]
4. Prognostic role of neutrophil-lymphocyte ratio in operable esophageal squamous cell carcinoma. Duan H; Zhang X; Wang FX; Cai MY; Ma GW; Yang H; Fu JH; Tan ZH; Meng YQ; Fu XY; Ma QL; Lin P World J Gastroenterol; 2015 May; 21(18):5591-7. PubMed ID: 25987784 [TBL] [Abstract][Full Text] [Related]
5. The preoperative systemic immune-inflammation index is associated with an unfavorable prognosis for patients undergoing curative resection of esophageal squamous cell carcinoma after neoadjuvant therapy. Obata Y; Kanda M; Shimizu D; Takami H; Inokawa Y; Hattori N; Hayashi M; Tanaka C; Nakayama G; Kodera Y Surg Today; 2023 Aug; 53(8):964-972. PubMed ID: 36797438 [TBL] [Abstract][Full Text] [Related]
6. Prognostic significance of preoperative absolute peripheral monocyte count in esophageal squamous cell carcinoma. Han L; Jia Y; Song Q; Wang N; Wang J; Bai B; Chen X; Wang C; Cheng Y Dis Esophagus; 2016 Oct; 29(7):740-746. PubMed ID: 26316375 [TBL] [Abstract][Full Text] [Related]
7. Preoperative systemic inflammation score (SIS) is superior to neutrophil to lymphocyte ratio (NLR) as a predicting indicator in patients with esophageal squamous cell carcinoma. Fu X; Li T; Dai Y; Li J BMC Cancer; 2019 Jul; 19(1):721. PubMed ID: 31331297 [TBL] [Abstract][Full Text] [Related]
8. Clinical utility of the systemic immune-inflammation index for predicting survival in esophageal squamous cell carcinoma after radical radiotherapy. Wang Y; Lyu J; Jia H; Liang L; Xiao L; Liu Y; Liu X; Li K; Chen T; Zhang R; Zhang H; Tang C; Li T Future Oncol; 2021 Jul; 17(20):2647-2657. PubMed ID: 34008415 [TBL] [Abstract][Full Text] [Related]
9. Cumulative score based on preoperative plasma fibrinogen and serum C-reactive protein could predict long-term survival for esophageal squamous cell carcinoma. Tian R; Yan H; Zhang F; Sun P; Wu AR; Zhang M; Jiang YL; Wu J; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J Oncotarget; 2016 Sep; 7(38):61533-61543. PubMed ID: 27517497 [TBL] [Abstract][Full Text] [Related]
10. The status of perineural invasion predicts the outcomes of postoperative radiotherapy in locally advanced esophageal squamous cell carcinoma. Ning ZH; Zhao W; Li XD; Chen LJ; Xu B; Gu WD; Shao YJ; Xu Y; Huang J; Pei HL; Jiang JT Int J Clin Exp Pathol; 2015; 8(6):6881-90. PubMed ID: 26261575 [TBL] [Abstract][Full Text] [Related]
11. Prognostic significance of preoperative lymphocyte-monocyte ratio in patients with resectable esophageal squamous cell carcinoma. Han LH; Jia YB; Song QX; Wang JB; Wang NN; Cheng YF Asian Pac J Cancer Prev; 2015; 16(6):2245-50. PubMed ID: 25824745 [TBL] [Abstract][Full Text] [Related]
12. Plasma fibrinogen levels are correlated with postoperative distant metastasis and prognosis in esophageal squamous cell carcinoma. Zhang D; Zhou X; Bao W; Chen Y; Cheng L; Qiu G; Sheng L; Ji Y; Du X Oncotarget; 2015 Nov; 6(35):38410-20. PubMed ID: 26334098 [TBL] [Abstract][Full Text] [Related]
13. Systemic immune-inflammation index (SII) is a useful prognostic indicator for patients with squamous cell carcinoma of the esophagus. Feng JF; Chen S; Yang X Medicine (Baltimore); 2017 Jan; 96(4):e5886. PubMed ID: 28121932 [TBL] [Abstract][Full Text] [Related]
14. Systemic immune-inflammation index (SII) is useful to predict survival outcomes in patients with surgically resected esophageal squamous cell carcinoma. Gao Y; Guo W; Cai S; Zhang F; Shao F; Zhang G; Liu T; Tan F; Li N; Xue Q; Gao S; He J J Cancer; 2019; 10(14):3188-3196. PubMed ID: 31289589 [No Abstract] [Full Text] [Related]
15. The Preoperative Neutrophil-To-Lymphocyte Ratio Is a Novel Immune Parameter for the Prognosis of Esophageal Basaloid Squamous Cell Carcinoma. Xiao Q; Zhang B; Deng X; Wu J; Wang H; Wang Y; Wang W PLoS One; 2016; 11(12):e0168299. PubMed ID: 27959959 [TBL] [Abstract][Full Text] [Related]
16. The preoperative sensitive-modified Glasgow prognostic score is superior to the modified Glasgow prognostic score in predicting long-term survival for esophageal squamous cell carcinoma. Tian R; Zhang F; Sun P; Wu J; Yan H; Wu AR; Zhang M; Jiang YL; Lu YH; Xu QY; Zhan XH; Zhang RX; Qian LT; He J Oncotarget; 2016 Oct; 7(41):67485-67494. PubMed ID: 27528228 [TBL] [Abstract][Full Text] [Related]
17. Prechemotherapy neutrophil : lymphocyte ratio is superior to the platelet : lymphocyte ratio as a prognostic indicator for locally advanced esophageal squamous cell cancer treated with neoadjuvant chemotherapy. Ji WH; Jiang YH; Ji YL; Li B; Mao WM Dis Esophagus; 2016 Jul; 29(5):403-11. PubMed ID: 25625421 [TBL] [Abstract][Full Text] [Related]
18. Prognostic value of pre-operative serum uric acid levels in esophageal squamous cell carcinoma patients who undergo R0 esophagectomy. Chen YF; Li Q; Chen DT; Pan JH; Chen YH; Wen ZS; Zeng WA Cancer Biomark; 2016 Jun; 17(1):89-96. PubMed ID: 27314297 [TBL] [Abstract][Full Text] [Related]
19. Tumor-Infiltrating CD4+ Lymphocytes Predict a Favorable Survival in Patients with Operable Esophageal Squamous Cell Carcinoma. Chen K; Zhu Z; Zhang N; Cheng G; Zhang F; Jin J; Wu J; Ying L; Mao W; Su D Med Sci Monit; 2017 Sep; 23():4619-4632. PubMed ID: 28949934 [TBL] [Abstract][Full Text] [Related]
20. Fibrinogen promotes malignant biological tumor behavior involving epithelial-mesenchymal transition via the p-AKT/p-mTOR pathway in esophageal squamous cell carcinoma. Zhang F; Wang Y; Sun P; Wang ZQ; Wang DS; Zhang DS; Wang FH; Fu JH; Xu RH; Li YH J Cancer Res Clin Oncol; 2017 Dec; 143(12):2413-2424. PubMed ID: 28801734 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]